Cipla's Bengaluru plant gets single FDA observation after cGMP inspection
For any FDA-approved facility, it is mandatory to conform to the US regulator's cGMP or current Good Manufacturing Practice regulations. Shares of Cipla Ltd ended at ₹1,464.85, down by ₹11.70, or 0.79%, on the BSE on May 30.

What's Your Reaction?






